Levels of CC motif chemokine 22 (CCL22) and IL-13, but not levels of
IL-5, predict response to mepolizumab in asthma
- Ayobami Akenroye
, - Tanawin Nopsopon
, - Hacker, JJ,
- Tanya Laidlaw
Ayobami Akenroye

Brigham and Women's Hospital
Corresponding Author:aakenroye@bwh.harvard.edu
Author Profile